Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.

Mutations in the transcription factor GATA2 underlie the syndrome of monocytopenia and B- and natural killer (NK)-cell lymphopenia associated with opportunistic infections and cancers. In addition, patients have recurrent and severe viral infections. NK cells play a critical role in mediating antiviral immunity. Human NK cells are thought to mature in a linear fashion, with the CD56(bright) stage preceding terminal maturation to the CD56(dim) stage, considered the most enabled for cytotoxicity. Here we report an NK cell functional defect in GATA2-deficient patients and extend this genetic lesion to what is considered to be the original NK cell-deficient patient. In most cases, GATA2 deficiency is accompanied by a severe reduction in peripheral blood NK cells and marked functional impairment. The NK cells detected in peripheral blood of some GATA2-deficient patients are exclusively of the CD56(dim) subset, which is recapitulated on in vitro NK cell differentiation. In vivo, interferon α treatment increased NK cell number and partially restored function but did not correct the paucity of CD56(bright) cells. Thus, GATA2 is required for the maturation of human NK cells and the maintenance of the CD56(bright) pool in the periphery. Defects in GATA2 are a novel cause of profound NK cell dysfunction.

[1]  Kirby D. Johnson,et al.  GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. , 2013, Blood.

[2]  Arndt Borkhardt,et al.  Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27 , 2013, Haematologica.

[3]  L. Bezrodnik,et al.  Human Natural Killer Cell Maturation Defect Supports In Vivo CD56bright to CD56dim Lineage Development , 2012, PloS one.

[4]  Kirby D. Johnson,et al.  Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. , 2012, The Journal of clinical investigation.

[5]  J. Orange,et al.  Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency. , 2012, Blood.

[6]  J. Orange,et al.  CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. , 2012, The Journal of allergy and clinical immunology.

[7]  J. Rosenfeld,et al.  Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. , 2012, Blood.

[8]  Sahar Mansour,et al.  Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome) , 2011, Nature Genetics.

[9]  Bernard Keavney,et al.  Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. , 2011, Blood.

[10]  Smita Y. Patel,et al.  Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. , 2011, Blood.

[11]  A. Dutra,et al.  Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications , 2011, Haematologica.

[12]  Anna L. Brown,et al.  Heritable GATA2 Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia , 2011, Nature Genetics.

[13]  J. Orange,et al.  IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function. , 2011, The Journal of clinical investigation.

[14]  N. McGovern,et al.  The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency , 2011, The Journal of experimental medicine.

[15]  Adeline R. Whitney,et al.  Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. , 2010, Blood.

[16]  Tariq Enver,et al.  GATA-2 regulates granulocyte-macrophage progenitor cell function. , 2008, Blood.

[17]  C. Lutz,et al.  Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15. , 2008, Experimental hematology.

[18]  R. Sun,et al.  Bcl-xL is associated with the anti-apoptotic effect of IL-15 on the survival of CD56(dim) natural killer cells. , 2008, Molecular immunology.

[19]  T. Enver,et al.  CD56bright Human NK Cells Differentiate into CD56dim Cells: Role of Contact with Peripheral Fibroblasts , 2007, The Journal of Immunology.

[20]  J. Orange.  Human natural killer cell deficiencies , 2006, Current opinion in allergy and clinical immunology.

[21]  M. Caligiuri,et al.  Human natural killer cell development , 2006, Immunological reviews.

[22]  Tariq Enver,et al.  Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. , 2005, Blood.

[23]  J. Casanova,et al.  Fatal varicella associated with selective natural killer cell deficiency. , 2005, The Journal of pediatrics.

[24]  Dolca Thomas,et al.  Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Elaine Dzierzak,et al.  GATA-2 Plays Two Functionally Distinct Roles during the Ontogeny of Hematopoietic Stem Cells , 2004, The Journal of experimental medicine.

[26]  W. Pichler,et al.  Strong αβ and γδ TCR response in a patient with disseminated Mycobacterium avium infection and lack of NK cells and monocytopenia , 2000 .

[27]  J. D. Engel,et al.  The mouse GATA-2 gene is expressed in the para-aortic splanchnopleura and aorta-gonads and mesonephros region. , 1999, Blood.

[28]  S. Orkin,et al.  Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. , 1997, Blood.

[29]  Y. Kitamura,et al.  Abundant expression of transcription factor GATA-2 in proliferating but not in differentiated mast cells in tissues of mice: demonstration by in situ hybridization. , 1996, Blood.

[30]  D Orlic,et al.  Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Stuart H. Orkin,et al.  An early haematopoietic defect in mice lacking the transcription factor GATA-2 , 1994, Nature.

[32]  J. Kemp,et al.  A patient with simultaneous absence of "classical" natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset. , 1990, The Journal of allergy and clinical immunology.

[33]  J L Sullivan,et al.  Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.

[34]  Jeffrey S. Miller,et al.  In vitro development of human Killer-Immunoglobulin Receptor-positive NK cells. , 2010, Methods in molecular biology.

[35]  W. Pichler,et al.  Strong alpha beta and gamma delta TCR response in a patient with disseminated Mycobacterium avium infection and lack of NK cells and monocytopenia. , 2000, Immunology letters.